Aerovate Therapeutics Organization
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Connections from
Industry:
PharmTech
Technology:
Anti-infective Drugs
Total Funding:
72600000
Last Funding Type:
Series A
Investor Type:
Healthcare Company
Headquarters:
Boston, Massachusetts, United States
Funding Status:
IPO
Employee Number:
1-10
Founded Date:
2019